In patients with type 2 diabetes [78], long-term treatment with GLP-1 analogs reduces blood pressure, an effect well observed before significant weight loss and potentially mediated by GLP-1’s natriuretic effect and/or by improved endothelial function. Here, GCG is linked to type 2 diabetes mellitus.